In € millions
20061
2007
2008
2009
1
Excluding Organon BioSciences, divested in 2007.
2
Before incidentals.
3
At year-end.
The Netherlands
US and Canada
Revenue by destination
783
777
867
807
1,855
3,330
2,985
Revenue by origin
1,325
1,368
1,423
1,284
1,898
1,871
3,463
3,166
EBIT2
(24)
103
18
(49)
151
136
154
82
Operating income
(19)
(6)
(45)
(69)
189
118
(608)
70
Capital expenditures
98
83
86
104
48
56
94
68
Invested capital3
1,216
893
2,007
1,490
1,195
1,214
3,250
3,020
Number of employees3
5,100
4,900
5,000
4,800
5,900
6,100
12,000
11,100
Germany
Latin America
962
907
1,141
1,121
566
606
1,306
1,232
959
930
1,179
1,197
431
475
1,103
1,040
73
66
115
100
64
58
135
128
47
59
(34)
54
62
89
15
17
25
21
14
49
33
384
365
1,086
1,064
253
272
776
960
3,200
3,100
3,600
3,900
2,500
2,700
4,500
Sweden
China
463
472
478
428
636
687
1,054
1,044
1,243
1,406
1,457
658
968
951
93
156
157
124
110
144
163
95
126
(98)
162
78
53
50
37
31
38
67
573
564
557
487
180
142
861
944
3,800
3,700
3,500
6,300
UK
Other Asian countries
567
552
1,093
816
743
784
1,866
1,704
633
617
1,206
851
520
1,682
1,549
(16)
153
87
79
85
199
254
–
12
(48)
84
76
(110)
249
22
7
10
43
29
309
486
1,324
1,614
227
195
1,030
938
3,000
4,200
3,300
7,800
7,400
Other European countries
Other regions
3,147
3,666
3,174
430
614
582
2,101
2,068
2,582
2,211
277
257
352
360
186
216
45
46
289
113
23
28
61
81
5
8
6
1,034
950
2,359
2,541
133
116
174
143
9,500
9,000
10,100
9,400
1,700
2,400
2,300
All sites